SCHEMBL3528955

SCHEMBL3528955

FC(F)(F)Oc1ccccc1.O=S(=O)(F)F

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.47
KIF11 P52732 2/20 0.44
KAT6A Q92794 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
SLC22A12 Q96S37 1/20 0.43
EPHX2 P34913 2/20 0.42
LIPE Q05469 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
CETP P11597 1/20 0.41
NOD1 Q9Y239 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
LTA4H P09960 1/20 0.41
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170370 0.89 NR3C1 (0.46) NR3C1KIF11KAT6AMEN1KMT2A
SCHEMBL168125 0.88 KIF11 (0.47) KIF11MEN1KMT2AEPHX2CYP1A2
SCHEMBL4036806 0.85 KIF11 (0.46) KIF11MEN1KMT2AEPHX2CYP1A2
SCHEMBL29087324 0.85 KIF11 (0.46) KIF11MEN1KMT2AEPHX2CYP1A2
Fluoride SCHEMBL28371495 0.85 KIF11 (0.46) KIF11MEN1KMT2AEPHX2CYP1A2
SCHEMBL4036809 0.85 KIF11 (0.46) KIF11MEN1KMT2AEPHX2CYP1A2
Ammonia Solution, Strong SCHEMBL2163079 0.85 KIF11 (0.46) KIF11MEN1KMT2AEPHX2CYP1A2
SCHEMBL7498053 0.85 KAT6A (0.44) NR3C1KIF11KAT6AMEN1KMT2A
Nitrogen SCHEMBL29122681 0.83 KIF11 (0.44) KIF11KAT6AMEN1KMT2AEPHX2
Ethyne SCHEMBL28472442 0.83 KIF11 (0.44) KIF11MEN1KMT2AEPHX2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642272-B2 Cannabinoid receptor ligands SCHERING CORPORATION (US) 2010-01-05 US disclosed
EP-1611090-A2 CANNABINOID RECEPTOR LIGANDS SCHERING CORPORATION (US) 2006-01-04 EP disclosed
WO-2004085385-A2 CANNABINOID RECEPTOR LIGANDS SCHERING CORPORATION (US) 2004-10-07 WO disclosed
US-20040186148-A1 Cannabinoid receptor ligands SCHERING CORPORATION 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186148-A1 Cannabinoid receptor ligands CNR1, CNR2, TRPV1 NR3C1 294/4885KIF11 4529/4885KAT6A 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.